Cipla Ltd. — Board/Management Information 2026

Mar 30, 2026

• (1) BSE Limited Listing Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 500087
• (2) National Stock Exchange of India Limited Listing Department Exchange Plaza, 5th floor, Plot no. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Symbol: CIPLA
• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby notify the following outcome of the meeting of the Board of Directors of the Company held on 30th March, 2026:

• 1. Upon Mr Achin Gupta taking charge as the Managing Director and Global Chief Executive officer, the following officials, who report directly to Mr Achin Gupta, have been categorised as Senior Management Personnel (SMP) of the Company w.e.f. 1st April, 2026:
  • Mr Saurabh Gambhir, Head Strategy and M&A (Global)
  • Mr Satyavan Manikani, Chief Portfolio Head Global
• 1. Upon completion of term as the Managing Director and Global Chief Executive Officer of the Company on 31st March, 2026, Mr Umang Vohra (DIN: 02296740) has resigned as a Director of the Company w.e.f. 1 st April, 2026. A copy of the resignation letter received from Mr Umang Vohra is enclosed.

The details required to be disclosed under the SEBI Circular no. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated 30th January 2026 for matters 1 and 2 are enclosed as Annexure I and II respectively.

Please take the above information on record.

Yours faithfully, For Cipla Limited RAJENDR A CHOPRA Digitally signed by RAJENDRA CHOPRA Date: 2026.03.30 18:11:04 +05'30'

Rajendra Chopra Company Secretary

Prepared by: Pavankumar Yadav

Annexure – I

Details as per SEBI circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026

Name of SMP	Mr Saurabh Gambhir
Reason for change viz. appointment,resignation,removal,deathorotherwise	Upon Mr Achin Gupta taking charge as the Managing Director andGlobal Chief Executive officer, Mr Saurabh Gambhir, who reportdirectly to Mr Achin Gupta, have been categorised as Senior
Date of appointment /cessation &term of appointment	Management Personnel of the Company w.e.f. 1st April, 2026.Terms of appointment: Full-time employment
Brief Profile (in case of appointment)	Mr Saurabh Gambhir is the Head –Strategy and Mergers &Acquisitions (Global) at Cipla. He plays a critical role in shaping Cipla'slong-termstrategicdirectionanddrivingkeytransformationinitiatives across global markets.Prior to joining Cipla, Saurabh held senior leadership roles at Emcure
	Pharmaceuticals and Intas Pharmaceuticals, where he led portfoliostrategy, marketing, and business development across multipletherapeutic segments. Earlier in his career, he worked with IMSHealth (now IQVIA), advising leading healthcare organisations ongrowth strategy and market expansion initiatives.
	At Cipla, Saurabh is responsible for leading strategic planning,inorganic growth opportunities, and digital transformation programs.His expertise in portfolio optimisation, commercial strategy, andoperational excellence has significantly contributed to strengtheningCipla's competitive positioning and future growth roadmap.
	Saurabh holds a Master of Business Administration degree from theIndian Institute of Management, Ahmedabad, and a Bachelor'sdegree in Engineering.
Disclosure of relationships betweendirectors (in case of appointment of adirector).	Not applicable

Annexure – I

Details as per SEBI circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026

Name of SMP	Mr Satyavan Manikani
Reason for change viz. appointment,resignation,removal,deathorotherwise	Upon Mr Achin Gupta taking charge as the Managing Director andGlobal Chief Executive officer, Mr Satyavan Manikani, who reportdirectly to Mr Achin Gupta, have been categorised as Senior
Date of appointment /cessation &term of appointment	Management Personnel of the Company w.e.f. 1st April, 2026.Terms of appointment: Full-time employment
Brief Profile (in case of appointment)	MrSatyavan Manikani is the Chief Portfolio Head Global at Cipla, heplays a critical role in shaping the Portfolio initiatives at Cipla,Globally.
	Prior to joining Cipla, Satyavan held leadership roles at USV LimitedGufic Biosciences Ltd, Alkem Labs, Ranbaxy Labs. Satyavan joinedCipla in February 2022 and since then has been leading portfolio forthe Indian market, shaping our domestic portfolio priorities inmultiple therapy areas, driving successful launches, and aligningIndia's portfolio strategy with Cipla's global vision.
	Satyavan is a Pharmacy graduate with an MBA in Marketing from theInstitute of Technology & Management, Mumbai.
Disclosure of relationships betweendirectors (in case of appointment of adirector).	Not applicable

Annexure II

Details as per SEBI circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026

DIN	02296740
Name of Director	Mr Umang Vohra
Reason for change viz.appointment,resignation,removal,deathorotherwiseDate of appointment / cessation &term of appointment	Upon completion of term as the Managing Director and GlobalChief Executive Officer of the Company on 31st March, 2026,Mr Umang Vohra has resigned as a Director of the Company w.e.f.1stApril, 2026.
Brief Profile (in case of appointment)	Not applicable
Disclosure of relationships betweendirectors (in case of appointment ofa director).	Not applicable
Information as required pursuant toBSE circular with ref. no. LIST/COMP/ 14/ 2018- 19 dated 20th June2018 and the NSE circular ref. no.NSE/ CML/ 2018/24 dated 20th June2018.	Not applicable

Umang Vohra

446 NASSAU ST, PRINCETON BORO NJ, 08540-4612, New Jersey, United States

Date:

To,

The Board of Directors, Cipla Limited, Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Pa rel, Mumbai, Maharashtra, 400013

Sub: Resignation as Director of Cipla Limited (the "Company")

Respected members of the Board,

As I will be completing my tenure as the Managing Director and Global Chief Executive Officer of the Company on 31st March, 2026, and do not wish to seek re-appointment, I hereby tender my resignation from the office of Director of Cipla Limited, with effect from 1st April, 2026.

My ten years at Cipla has been filled with immense pride in what we've built together. Guided by our purpose of Caring for Life, I have had the privilege of working with passionate teams who consistently put patients first and drive innovation across the business. I am deeply grateful to our Chairman, Dr Y K Hamied, and the Board for their trust and support throughout this journey.

I take this opportunity to thank the Board and my colleagues for their continued collaboration and wish the Company sustained success in the years ahead.

Your sincerely,

UmangVohra DIN:02296740